|
|
|
| Outsourced Pharma Capabilities Update - ADCs | This digital event focuses on antibody-drug conjugates (ADCs) and how CDMOs support their development from early stages through clinical and commercial manufacturing. It highlights the importance of selecting the right partner for these complex therapies, including expertise in conjugation processes, scalability, regulatory needs, and integrated development services. Attendees will learn key criteria for evaluating CDMOs and how to align partnerships to accelerate ADC program success. Click here to learn more. |
|
|
|
| Redefining Prefillable Syringe System | Infographic | West Pharmaceutical Services, Inc. | This step-by-step flow helps guide teams from early feasibility assessments all the way through to regulatory submission, with greater clarity at each stage. |
|
|
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | Confirming data is now at hand. In 2005, we suggested Europe’s CDMOs couldn’t wait for a political or trade détente vis-à-vis the U.S. If they actively leveraged their reputation for reliability, tariffs would not meaningfully redirect manufacturing to the U.S. Here's an analysis of a GlobalData report on what has transpired. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| Safely Scaling High Potency API Manufacturing | White Paper | Recipharm | Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up. |
|
|
| Why Early Formulation Decisions Matter | Article | Thermo Fisher Scientific | Rushed OSD formulation decisions create costly downstream failures. Learn how strategic early-phase planning reduces CMC holds, scale-up risks, and regulatory delays. |
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
